DRUG · Mapped RxNorm record
donepezil
Normalized identity: donepezil View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg
NCT02550665
Study summary
ClinicalTrials.govOptimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Advertisement
Conditions
Alzheimer's Diseaseverified · MONDO: Alzheimer disease
Interventions
donepezilDRUG · verified · RxNorm: donepezil
Sponsors & collaborators
Asan Medical Centerlead sponsor
Dong-A Universitycollaborator
Myongji Hospitalcollaborator
Seoul National University Bundang Hospitalcollaborator
Seoul St. Mary's Hospitalcollaborator
Chung-Ang Universitycollaborator
Eisai Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02550665 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.